RUNX2 Mediates Plasmacytoid Dendritic Cell Egress from the Bone Marrow and Controls Viral Immunity.

[1]  J. Cyster,et al.  CXCR4 and a cell-extrinsic mechanism control immature B lymphocyte egress from bone marrow , 2014, The Journal of experimental medicine.

[2]  J. Visvader,et al.  Runx2 is a novel regulator of mammary epithelial cell fate in development and breast cancer. , 2014, Cancer research.

[3]  C. Leclerc,et al.  Conventional but Not Plasmacytoid Dendritic Cells Foster the Systemic Virus–Induced Type I IFN Response Needed for Efficient CD8 T Cell Priming , 2014, Journal of Immunology.

[4]  Ansuman T. Satpathy,et al.  Runx1 and Cbfβ regulate the development of Flt3+ dendritic cell progenitors and restrict myeloproliferative disorder. , 2014, Blood.

[5]  J. Pike,et al.  The RUNX2 Cistrome in Osteoblasts , 2014, The Journal of Biological Chemistry.

[6]  Y. Saunthararajah,et al.  Runx1 Regulation of Pu.1 Corepressor/Coactivator Exchange Identifies Specific Molecular Targets for Leukemia Differentiation Therapy* , 2014, The Journal of Biological Chemistry.

[7]  John T. Chang,et al.  Early specification of CD8+ T lymphocyte fates during adaptive immunity revealed by single-cell gene expression analyses , 2014, Nature Immunology.

[8]  Stéphane Chevrier,et al.  Langerhans cells are generated by two distinct PU.1-dependent transcriptional networks , 2013, The Journal of experimental medicine.

[9]  Jianzhu Chen,et al.  A genome-wide regulatory network identifies key transcription factors for memory CD8+ T-cell development , 2013, Nature Communications.

[10]  Boris Reizis,et al.  Transcription factor Runx2 controls the development and migration of plasmacytoid dendritic cells , 2013, The Journal of experimental medicine.

[11]  M. Colonna,et al.  Plasmacytoid Dendritic Cells Contribute to Systemic but Not Local Antiviral Responses to HSV Infections , 2013, PLoS pathogens.

[12]  K. Crozat,et al.  Plasmacytoid, conventional, and monocyte-derived dendritic cells undergo a profound and convergent genetic reprogramming during their maturation , 2013, European journal of immunology.

[13]  W. Shi,et al.  The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote , 2013, Nucleic acids research.

[14]  Daigo Hashimoto,et al.  Deciphering the transcriptional network of the DC lineage , 2012, Nature Immunology.

[15]  R. Schreiber,et al.  Timing and magnitude of type I interferon responses by distinct sensors impact CD8 T cell exhaustion and chronic viral infection. , 2012, Cell host & microbe.

[16]  W. Reith,et al.  Plasmacytoid dendritic cells control T-cell response to chronic viral infection , 2012, Proceedings of the National Academy of Sciences.

[17]  R. Schreiber,et al.  Type I interferon negatively controls plasmacytoid dendritic cell numbers in vivo , 2011, The Journal of experimental medicine.

[18]  B. Reizis,et al.  Continuous expression of the transcription factor e2-2 maintains the cell fate of mature plasmacytoid dendritic cells. , 2010, Immunity.

[19]  M. Colonna,et al.  Plasmacytoid dendritic cell ablation impacts early interferon responses and antiviral NK and CD8(+) T cell accrual. , 2010, Immunity.

[20]  V. Lougaris,et al.  Defect of plasmacytoid dendritic cells in warts, hypogammaglobulinemia, infections, myelokathexis (WHIM) syndrome patients. , 2010, Blood.

[21]  B. Malissen,et al.  Comparative genomics as a tool to reveal functional equivalences between human and mouse dendritic cell subsets , 2010, Immunological reviews.

[22]  J. Cyster,et al.  Cannabinoid receptor 2 mediates retention of immature B cells in bone marrow sinusoids , 2009, Nature Immunology.

[23]  Manfred Lehner,et al.  Transcription Factor E2-2 Is an Essential and Specific Regulator of Plasmacytoid Dendritic Cell Development , 2008, Cell.

[24]  N. Fujii,et al.  Development of plasmacytoid dendritic cells in bone marrow stromal cell niches requires CXCL12-CXCR4 chemokine signaling. , 2007, Blood.

[25]  S. Akira,et al.  Lymphocytoid Choriomeningitis Virus Activates Plasmacytoid Dendritic Cells and Induces a Cytotoxic T-Cell Response via MyD88 , 2007, Journal of Virology.

[26]  Lucia Gabriele,et al.  The feedback phase of type I interferon induction in dendritic cells requires interferon regulatory factor 8. , 2007, Immunity.

[27]  S. Akira,et al.  Control of coronavirus infection through plasmacytoid dendritic-cell–derived type I interferon , 2007, Blood.

[28]  Christie M. Orschell,et al.  Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist , 2005, The Journal of experimental medicine.

[29]  Hideo Negishi,et al.  IRF-7 is the master regulator of type-I interferon-dependent immune responses , 2005, Nature.

[30]  K. Arai,et al.  Ly49Q defines 2 pDC subsets in mice. , 2005, Blood.

[31]  B. Wood,et al.  Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist. , 2003, Blood.

[32]  Christophe Caux,et al.  The Inducible CXCR3 Ligands Control Plasmacytoid Dendritic Cell Responsiveness to the Constitutive Chemokine Stromal Cell–derived Factor 1 (SDF-1)/CXCL12 , 2003, The Journal of experimental medicine.

[33]  J. Rodríguez-Fernández,et al.  Migration of human blood dendritic cells across endothelial cell monolayers: adhesion molecules and chemokines involved in subset‐specific transmigration , 2003, Journal of leukocyte biology.

[34]  Rudolf Jaenisch,et al.  Rapid generation of inducible mouse mutants. , 2003, Nucleic acids research.

[35]  L. Adorini,et al.  Differential migration behavior and chemokine production by myeloid and plasmacytoid dendritic cells. , 2002, Human immunology.

[36]  Ravindra Uppaluri,et al.  Cutting Edge: IFN-Producing Cells Respond to CXCR3 Ligands in the Presence of CXCL12 and Secrete Inflammatory Chemokines upon Activation1 , 2002, The Journal of Immunology.

[37]  Brendan H. Lee,et al.  A natural history of cleidocranial dysplasia. , 2001, American journal of medical genetics.

[38]  A. Zlotnik,et al.  Chemokines: a new classification system and their role in immunity. , 2000, Immunity.

[39]  D. Jarrossay,et al.  Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon , 1999, Nature Medicine.

[40]  N. Kadowaki,et al.  The nature of the principal type 1 interferon-producing cells in human blood. , 1999, Science.

[41]  D. Levy,et al.  Differential viral induction of distinct interferon‐α genes by positive feedback through interferon regulatory factor‐7 , 1998, The EMBO journal.

[42]  D. Tenen,et al.  Multiple Functional Domains of AML1: PU.1 and C/EBPα Synergize with Different Regions of AML1 , 1998, Molecular and Cellular Biology.

[43]  S. Mundlos,et al.  Cbfa1, a Candidate Gene for Cleidocranial Dysplasia Syndrome, Is Essential for Osteoblast Differentiation and Bone Development , 1997, Cell.

[44]  M. Owen,et al.  Mutations Involving the Transcription Factor CBFA1 Cause Cleidocranial Dysplasia , 1997, Cell.

[45]  Makoto Sato,et al.  Targeted Disruption of Cbfa1 Results in a Complete Lack of Bone Formation owing to Maturational Arrest of Osteoblasts , 1997, Cell.

[46]  R M Zinkernagel,et al.  Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24- or 96-well plates. , 1991, Journal of virological methods.

[47]  L. Rönnblom,et al.  Characterization of interferons induced by bacteria and interferon-producing leukocytes in human peripheral blood , 1983, Infection and immunity.